Thursday, February 25
Shadow

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial – The BMJ

Sorry, Readability was unable to parse this page for content.

Leave a Reply

Your email address will not be published. Required fields are marked *